Hardee G[au] - Search Results

Year	Number of Results
1978	3
1979	1
1981	2
1982	1
1983	1
1984	2
1985	4
1986	3
1987	2
1991	1
1994	1
1997	1
1999	1
2000	2
2001	3
2002	3
2003	4
2004	2
2005	3
2008	2
2012	2
2022	0

1

Oral delivery of nucleic acid-based therapeutics.

Hardee GE. Hardee GE. Ther Deliv. 2012 Feb;3(2):143-5. doi: 10.4155/tde.11.143. Ther Deliv. 2012. PMID: 22834192 Free article. No abstract available.

2

Pharmacokinetics of flunixin meglumine in dogs.

Hardie EM, Hardee GE, Rawlings CA. Hardie EM, et al. Among authors: hardee ge. Am J Vet Res. 1985 Jan;46(1):235-7. Am J Vet Res. 1985. PMID: 3970431

3

Oral delivery of antisense oligonucleotides in man.

Tillman LG, Geary RS, Hardee GE. Tillman LG, et al. Among authors: hardee ge. J Pharm Sci. 2008 Jan;97(1):225-36. doi: 10.1002/jps.21084. J Pharm Sci. 2008. PMID: 17721945

4

Microencapsulation of antimicrobial ceftiofur drugs.

Bodmeier R, Chen H, Davidson RG, Hardee GE. Bodmeier R, et al. Among authors: hardee ge. Pharm Dev Technol. 1997 Nov;2(4):323-34. doi: 10.3109/10837459709022631. Pharm Dev Technol. 1997. PMID: 9552461

5

Pheochromocytoma in the horse and measurement of norepinephrine levels in horses.

Yovich JV, Horney FD, Hardee GE. Yovich JV, et al. Among authors: hardee ge. Can Vet J. 1984 Jan;25(1):21-5. Can Vet J. 1984. PMID: 17422350 Free PMC article.

6

Can a virtual patient trainer teach student nurses how to save lives--teaching nursing students about pediatric respiratory diseases.

LeFlore JL, Anderson M, Zielke MA, Nelson KA, Thomas PE, Hardee G, John LD. LeFlore JL, et al. Among authors: hardee g. Simul Healthc. 2012 Feb;7(1):10-7. doi: 10.1097/SIH.0b013e31823652de. Simul Healthc. 2012. PMID: 22228285 Clinical Trial.

7

Dermal delivery of topically applied oligonucleotides via follicular transport in mouse skin.

Dokka S, Cooper SR, Kelly S, Hardee GE, Karras JG. Dokka S, et al. Among authors: hardee ge. J Invest Dermatol. 2005 May;124(5):971-5. doi: 10.1111/j.0022-202X.2005.23672.x. J Invest Dermatol. 2005. PMID: 15854038 Free article.

8

Transdermal delivery of antisense oligonucleotides with microprojection patch (Macroflux) technology.

Lin W, Cormier M, Samiee A, Griffin A, Johnson B, Teng CL, Hardee GE, Daddona PE. Lin W, et al. Among authors: hardee ge. Pharm Res. 2001 Dec;18(12):1789-93. doi: 10.1023/a:1013395102049. Pharm Res. 2001. PMID: 11785702 No abstract available.

9

Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres.

Freytag T, Dashevsky A, Tillman L, Hardee GE, Bodmeier R. Freytag T, et al. Among authors: hardee ge. J Control Release. 2000 Oct 3;69(1):197-207. doi: 10.1016/s0168-3659(00)00299-6. J Control Release. 2000. PMID: 11018557

10

Flunixin meglumine given in small doses: pharmacokinetics and prostaglandin inhibition in healthy horses.

Semrad SD, Hardee GE, Hardee MM, Moore JN. Semrad SD, et al. Among authors: hardee ge. Am J Vet Res. 1985 Dec;46(12):2474-9. Am J Vet Res. 1985. PMID: 4083579

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results